Workshop 03 - No Longer "Taboo": An Interactive Workshop for Providers Navigating Compassionate Conversations with Sexual and Gender Minority (SGM) Patients
Moderator: Laura Dawson, MD, FASTRO – Princess Margaret Cancer Centre, University Health Network, University of Toronto
Gastrointestinal CancerInternational
CE: 1.00
Tuesday, Oct 1st
12:45 PM – 2:00 PM ET
EDU 42 - Best Practices in the Multidisciplinary Management of Borderline Resectable and Unresectable Pancreatic Cancer as well as Extrahepatic/Perihilar Cholangiocarcinoma
PS 03 - Presidential Symposium: Innovations in Genitourinary Cancers: Session III - Radiotherapy for Prostate Cancer: Innovations You Can Implement Today
Moderator: Angela Jia, MD, PhD – Case Western Reserve University/University Hospitals Cleveland Medical Center
Genitourinary Cancer
CE: 1.00
Gynecological Cancer
Saturday, Sep 28th
5:00 PM – 6:15 PM ET
PRO 07 - Gynecologic Tumor Board - Case-Based Discussion of the Molecular and Treatment Approach Updates for the Management of Endometrial, Vulvar and Cervical Cancers
EDU 08 - Blood-Based Cancer Screening Tests: An Overview of Developing Technologies, Early Prospective Clinical Trial Results and Opportunities for Radiation Oncologists
EDU 47 - Intersection of Immuno-Molecular-Genetic Profiling and Implications for Immunotherapy (IT) and Immunotherapy-Radiotherapy (IT-RT) Combinations
The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal is Cure
Location: Marriott Marquis Washington, DC (Liberty Ballroom, Salons M/N/O/P)
Industry Satellite Symposium
Sunday, Sep 29th
6:00 PM – 8:30 PM ET
New Frontiers in Immunotherapy for SCLC: Insights from the Latest Clinical Trials and Their Application in Real-World Treatment
Location: Marriott Marquis Washington, DC (Marquis Ballroom 3-4)
Industry Satellite Symposium
Industry-Expert Theater
Sunday, Sep 29th
12:00 PM – 1:00 PM ET
AstraZeneca: The Role of Radiation Oncology in Managing Patients with Unresectable Stage III Non-Small Cell Lung Cancer
Location: Theater 2
Industry-Expert Theater
Sunday, Sep 29th
12:00 PM – 1:00 PM ET
Blue Earth Diagnostics, Inc.: Let’s Talk About POSLUMA® (flotufolastat F18)
Location: Theater 1
Industry-Expert Theater
Sunday, Sep 29th
12:00 PM – 1:00 PM ET
GE Healthcare: Data-Enhanced Strategies in Improving Radiation Therapy Outcomes
Location: Room 154
Industry-Expert Theater
Sunday, Sep 29th
2:00 PM – 3:00 PM ET
Accuray: Evolving Techniques in CNS Radiosurgery: Historical, Contemporary, and Future Directions
Location: Theater 2
Industry-Expert Theater
Sunday, Sep 29th
2:00 PM – 3:00 PM ET
BioProtect: Safely Dissecting the Data and Real-World Experience of Rectal Spacers: Redefining Precision and Safety with the BioProtect Balloon Implant
Location: Room 154
Industry-Expert Theater
Sunday, Sep 29th
2:00 PM – 3:00 PM ET
Sumitomo Heavy Industries, Ltd.: Clinical Experience with Accelerator Based BNCT (Boron Neutron Capture Therapy) System in Japan
Location: Theater 1
Industry-Expert Theater
Monday, Sep 30th
12:00 PM – 1:00 PM ET
Boston Scientific: The Evolution of Prostate Cancer Therapy: SpaceOAR Hydrogel's Clinical Impact and Future Directions
Location: Theater 2
Industry-Expert Theater
Monday, Sep 30th
12:00 PM – 1:00 PM ET
GammaTile: A Simple Solution to Complex Challenges in Brain Tumor Management
Location: Theater 1
Industry-Expert Theater
Monday, Sep 30th
12:00 PM – 1:00 PM ET
Lantheus: Impact of PSMA PET Imaging in the Management of Prostate Cancer
Location: Room 154
Industry-Expert Theater
Monday, Sep 30th
2:00 PM – 3:00 PM ET
Chimerix: The Role of Radiotherapy in the Treatment of H3 K27M-mutant Diffuse Midline Glioma (DMG)
Location: Theater 2
Industry-Expert Theater
Monday, Sep 30th
2:00 PM – 3:00 PM ET
Philips Healthcare: Better Care for More People with Philips Radiotherapy Solutions
Location: Theater 1
Industry-Expert Theater
Monday, Sep 30th
2:00 PM – 3:00 PM ET
Servier Pharmaceuticals: Targeted Therapy in mIDH Adult-Type Diffuse Glioma
Location: Room 154
Industry-Expert Theater
Tuesday, Oct 1st
12:00 PM – 1:00 PM ET
MIM Software: Reducing Time to Treatment with MIM
Location: Room 154
Industry-Expert Theater
Tuesday, Oct 1st
12:00 PM – 1:00 PM ET
Novartis Pharmaceutical Corporation: PSMA-Targeted Radioligand Therapy in mCRPC: A Precision Approach
Location: Theater 2
Industry-Expert Theater
Tuesday, Oct 1st
12:00 PM – 1:00 PM ET
Telix Pharmaceuticals: The Clinical Impact of PET/CT in Radiation Oncology
Location: Theater 1
Industry-Expert Theater
International
Sunday, Sep 29th
8:00 AM – 9:00 AM ET
International 01 - Implementing Innovations for Radiotherapy Delivery in Low- and Middle-Income Countries: Challenges and Opportunities
Workshop 03 - No Longer "Taboo": An Interactive Workshop for Providers Navigating Compassionate Conversations with Sexual and Gender Minority (SGM) Patients
PRO 07 - Gynecologic Tumor Board - Case-Based Discussion of the Molecular and Treatment Approach Updates for the Management of Endometrial, Vulvar and Cervical Cancers
EDU 08 - Blood-Based Cancer Screening Tests: An Overview of Developing Technologies, Early Prospective Clinical Trial Results and Opportunities for Radiation Oncologists
ASPP 01 - 2024 Aspiring Scientists and Physicians Program for Underrepresented Populations
Location: Room 143
Special Session
Sunday, Sep 29th
11:10 AM – 12:05 PM ET
PS 03 - Presidential Symposium: Innovations in Genitourinary Cancers: Session III - Radiotherapy for Prostate Cancer: Innovations You Can Implement Today